Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$4.57B |
| 2 |
Microsoft
MSFT
|
+$1.4B |
| 3 |
NVIDIA
NVDA
|
+$1.36B |
| 4 |
Amazon
AMZN
|
+$1.19B |
| 5 |
Broadcom
AVGO
|
+$1.13B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
WRK
WestRock Company
WRK
|
+$316M |
| 2 |
Vertex Pharmaceuticals
VRTX
|
+$187M |
| 3 |
Regeneron Pharmaceuticals
REGN
|
+$159M |
| 4 |
ETRN
Equitrans Midstream Corporation Common Stock
ETRN
|
+$139M |
| 5 |
Cadence Design Systems
CDNS
|
+$113M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.03% |
| 2 | Financials | 12.84% |
| 3 | Healthcare | 11.54% |
| 4 | Consumer Discretionary | 10.45% |
| 5 | Industrials | 8.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3051
TaskUs
TASK
$669M
| $2.52M | ﹤0.01% |
195,156
-23,692
| -11% | -$336K |
|
3052
Hagerty
HGTY
$1.39B
| $2.52M | ﹤0.01% |
247,449
-9,271
| -4% | -$103K |
|
3053
D-Wave Quantum Inc. Common Stock
QBTS
$7.73B
| $2.51M | ﹤0.01% |
2,555,927
+645,039
| +34% | +$645K |
|
3054
uniQure
QURE
$3.22B
| $2.51M | ﹤0.01% |
508,602
+6,362
| +1% | +$41.4K |
|
3055
Tenaya Therapeutics
TNYA
$163M
| $2.5M | ﹤0.01% |
1,296,156
+66,968
| +5% | +$189K |
|
3056
Sonida Senior Living
SNDA
$1.91B
| $2.5M | ﹤0.01% |
93,430
-14,683
| -14% | -$421K |
|
3057
Alvotech
ALVO
$1.29B
| $2.49M | ﹤0.01% |
209,257
+21,022
| +11% | +$244K |
|
3058
Cardiff Oncology
CRDF
$77.2M
| $2.48M | ﹤0.01% |
928,232
+17,557
| +2% | +$41.5K |
|
3059
SoundThinking
SSTI
$103M
| $2.48M | ﹤0.01% |
213,574
-2,758
| -1% | -$37.2K |
|
|
CTNM
3060
Contineum Therapeutics
CTNM
$566M
| $2.46M | ﹤0.01% |
128,676
-27,745
| -18% | -$532K |
|
3061
Harvard Bioscience
HBIO
$29.2M
| $2.46M | ﹤0.01% |
91,260
+1,997
| +2% | +$58.8K |
|
3062
Everspin Technologies
MRAM
$405M
| $2.44M | ﹤0.01% |
412,879
+1,941
| +0.5% | +$11.3K |
|
3063
NACCO Industries
NC
$320M
| $2.43M | ﹤0.01% |
85,852
-6,975
| -8% | -$197K |
|
|
BLUE
3064
DELISTED
bluebird bio
BLUE
| $2.43M | ﹤0.01% |
234,152
+8,338
| +4% | +$139K |
|
|
NKLA
3065
DELISTED
Nikola Corporation Common Stock
NKLA
| $2.4M | ﹤0.01% |
524,731
+53,966
| +11% | +$400K |
|
3066
Rezolute
RZLT
$452M
| $2.39M | ﹤0.01% |
491,601
+137,905
| +39% | +$633K |
|
3067
Galectin Therapeutics
GALT
$348M
| $2.37M | ﹤0.01% |
862,542
+20,817
| +2% | +$51.1K |
|
3068
IBEX
IBEX
$499M
| $2.35M | ﹤0.01% |
117,831
+76
| +0.1% | +$1.31K |
|
|
VRN
3069
DELISTED
Veren
VRN
| $2.35M | ﹤0.01% |
380,386
+15,594
| +4% | +$111K |
|
3070
QuickLogic
QUIK
$257M
| $2.35M | ﹤0.01% |
306,267
-5,449
| -2% | -$50.2K |
|
3071
Ramaco Resources Class B
METCB
$408M
| $2.34M | ﹤0.01% |
234,601
-39,712
| -14% | -$398K |
|
3072
Puma Biotechnology
PBYI
$454M
| $2.34M | ﹤0.01% |
917,367
-32,779
| -3% | -$99.2K |
|
3073
eGain
EGAN
$201M
| $2.33M | ﹤0.01% |
457,783
-10,308
| -2% | -$66.1K |
|
|
QVCGA
3074
DELISTED
QVC Group Inc Series A
QVCGA
| $2.33M | ﹤0.01% |
76,499
+3,362
| +5% | +$107K |
|
|
MPX
3075
DELISTED
Marine Products Corp
MPX
| $2.33M | ﹤0.01% |
240,735
+8,527
| +4% | +$82.1K |
|
Similar funds
Geode Capital Management's Q3 2024 Portfolio in Review
As of Q3 2024, Geode Capital Management held 4,685 positions worth $1.23T, up 8.4% from $1.14T the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Geode Capital Management's Q3 2024 filing shows 98 new, 3,266 increased, 979 reduced and 150 closed positions. Its largest new stake was Smurfit Westrock: 12,733,113 shares worth $627M. The largest sale was WestRock Company, an estimated $316M.
By sector, the portfolio is most concentrated in Technology at 31% of assets, down from 32% a quarter earlier, followed by Financials and Healthcare.
- Geode Capital Management's largest Q3 2024 buy was Smurfit Westrock: 12,733,113 shares worth $627M.
- Geode Capital Management added most to Apple in Q3 2024, an estimated $4.57B increase.
- Geode Capital Management's biggest Q3 2024 reduction was Vertex Pharmaceuticals, cutting an estimated $187M.
- Geode Capital Management fully exited WestRock Company in Q3 2024, selling an estimated $316M.
- Geode Capital Management's ten largest holdings make up 30% of its $1.23T portfolio in Q3 2024.
- Geode Capital Management opened 98 new positions and closed 150 in Q3 2024.
- Geode Capital Management's portfolio value rose 8.4% quarter-over-quarter to $1.23T.
Based on Geode Capital Management's 13F filing for Q3 2024, filed 12 Nov 2024.